1 results match your criteria: "New York University Medical Center (D.B.M.).[Affiliation]"
Use and performance of the Melody Transcatheter Pulmonary Valve in native and postsurgical, nonconduit right ventricular outflow tracts.
Circ Cardiovasc Interv
June 2014
From the Division of Cardiology, UCSF Benioff Children's Hospital, University of California, San Francisco (J.J.M., P.M.M.); Division of Cardiology, Miami Children's Hospital, FL (D.P.B.); Division of Cardiology, Nationwide Children's Hospital, Ohio State University School of Medicine, Columbus (J.P.C., S.L.C.); Department of Cardiology, Children's Hospital Boston, MA (D.P.); Division of Cardiology, The Children's Hospital of Philadelphia, PA (M.J.G., J.J.R.); Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA (E.M.Z.); and Division of Cardiology, New York University Medical Center (D.B.M.).
Background: Melody Transcatheter Pulmonary Valve (TPV) replacement therapy represents an important advance in congenital cardiovascular interventions. The off-label extension of the Melody TPV to patients with nonconduit outflow tracts (right ventricular outflow tract [RVOT]) has the potential to vastly expand the population of patients eligible to benefit from nonsurgical restoration of RVOT function. However, knowledge on the performance of the Melody TPV in this setting is limited.
View Article and Find Full Text PDF